Biocardia Daily News Today : Breaking News, Live Updates & Top Stories | Vimarsana

BioCardia, Inc (NASDAQ:BCDA) Short Interest Down 10 4% in May

BioCardia, Inc. (NASDAQ:BCDA – Get Free Report) was the recipient of a significant decline in short interest in May. As of May 15th, there was short interest totalling 235,400 shares, a decline of 10.4% from the April 30th total of 262,800 shares. Based on an average daily trading volume, of 325,000 shares, the short-interest ratio […]

United statesBiocardia incGet free reportBiocardia daily

BioCardia s (BCDA) Buy Rating Reiterated at HC Wainwright

BioCardia (NASDAQ:BCDA – Get Free Report)‘s stock had its “buy” rating reaffirmed by analysts at HC Wainwright in a note issued to investors on Wednesday, Benzinga reports. They presently have a $4.00 price objective on the stock. BioCardia Stock Down 0.9 % NASDAQ:BCDA traded down $0.00 during trading hours on Wednesday, reaching $0.35. The company […]

United statesBiocardia incGet free reportCardia stock downBiocardia daily

BioCardia (NASDAQ:BCDA) Releases Quarterly Earnings Results

BioCardia (NASDAQ:BCDA) Releases Quarterly Earnings Results
dailypolitical.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailypolitical.com Daily Mail and Mail on Sunday newspapers.

United statesBiocardia incGet free reportCardia trading downBiocardia daily

Short Interest in BioCardia, Inc (NASDAQ:BCDA) Grows By 927 5%

BioCardia, Inc. (NASDAQ:BCDA – Get Free Report) was the target of a significant growth in short interest in March. As of March 15th, there was short interest totalling 1,010,000 shares, a growth of 927.5% from the February 29th total of 98,300 shares. Based on an average daily trading volume, of 378,600 shares, the days-to-cover ratio […]

Peter altmanCm managementBiocardia company profileMillennium managementVirtu financialBlackrock incBiocardia incGeode capital managementSecurities exchange commissionGet free reportPhillip md et al frostExchange commissionCapital managementBiocardia dailyNasdaq bcda

BioCardia, Inc (NASDAQ:BCDA) CEO Buys $49,729 68 in Stock

BioCardia, Inc. (NASDAQ:BCDA – Get Free Report) CEO Peter Altman acquired 108,108 shares of the stock in a transaction that occurred on Tuesday, February 13th. The shares were acquired at an average cost of $0.46 per share, with a total value of $49,729.68. Following the transaction, the chief executive officer now owns 555,447 shares in […]

Peter altmanCm managementBiocardia incBiocardia company profileBlackrock incDimensional fund advisorsRenaissance technologiesSecurities exchange commissionMillennium managementGet free reportExchange commissionFund advisorsBiocardia dailyNasdaq bcdaInsider tradingNsider trades